CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine‐needle aspiration cytology samples
Diagnostic Cytopathology2019Vol. 48(3), pp. 211–216
Citations Over TimeTop 10% of 2019 papers
Immacolata Cozzolino, Giulio Vitagliano, Alessandro Caputo, Marco Montella, Renato Franco, Giuseppe Ciancia, Carmine Selleri, Pio Zeppa
Abstract
CD15, CD30, and PAX5 are useful to the FNAC identification of HC and RSC. CD30 is the most sensitive, followed by CD15 and PAX5, which are more effective on CB and smears, respectively.
Related Papers
- → CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine‐needle aspiration cytology samples(2019)37 cited
- → Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators(2012)13 cited
- → Hodgkin Lymphoma of the Nasopharynx: Case Report with Review of the Literature(2015)9 cited
- Hodgkin's disease and an extranodal marginal zone B-cell lymphoma in the small intestine: an unusual composite lymphoma.(1996)
- Analysis of PAX5 expression of Hodgkin’s and non-Hodgkin’s lymphomas: in comparison with routine panel(2021)